For instance, reports of HLA-A*02-specific CD8+ cytotoxic T cells recognizing the oncogenes EGFR and p53 in the circulation of HNSCC patients could account for the observed improved outcomes of HNSCC patients with this genotype [27,28]. Here, CD8A is linked to head and neck squamous cell carcinoma.